RecruitingNCT03549416

BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis

BioDay Registry: Prospective, Observational Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Diseases in Daily Practice

Sponsor

UMC Utrecht

Enrollment

1,200 participants

Start Date

Jan 1, 2018

Study Type

OBSERVATIONAL

Conditions

Atopic Dermatitis

Summary

The BioDay Registry aims to address the need for daily practice data regarding the effectiveness and safety of new systemic treatment options (like biologics and Janus kinase inhibitors) in patients with atopic dermatitis and effect on other atopic comorbidities in a multicenter setting. The registry already consists of several additional modules concerning atopic comorbidities, like food allergy and asthma, and a module for conjunctivitis during biologic treatment.

Eligibility

Min Age: 0 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with atopic dermatitis. The study is currently recruiting participants at 14 locations. People eligible for this study include aged 0 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(14)

Radboud University Medical Center

Nijmegen, Gelderland, Netherlands

Isala Dermatologisch Centrum

Zwolle, Overijssel, Netherlands

Medisch Centrum Leeuwarden

Leeuwarden, Provincie Friesland, Netherlands

University Medical Center Groningen

Groningen, Provincie Groningen, Netherlands

IJsselland Ziekenhuis

Capelle aan den IJssel, South Holland, Netherlands

University Medical Center Utrecht

Utrecht, Utrecht, Netherlands

Meander Medisch Centrum

Amersfoort, Netherlands

Reinier de Graaf ziekenhuis

Delft, Netherlands

Catharina ziekenhuis

Eindhoven, Netherlands

Spaarne Gasthuis

Haarlem, Netherlands

Maastricht Univeristy Medical Center

Maastricht, Netherlands

Haga ziekenhuis

The Hague, Netherlands

Diakonessenhuis

Utrecht, Netherlands

St Antonius ziekenhuis

Utrecht, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03549416

Related Trials

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

NCT072629831 location

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

NCT006058781 location

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

NCT0639791116 locations

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

NCT065994111 location

Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

NCT076458204 locations